nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Vitamin B12 deficiency—Metformin—metabolic syndrome X	0.206	0.207	CcSEcCtD
Esomeprazole—Fungal infection—Metformin—metabolic syndrome X	0.0279	0.0282	CcSEcCtD
Esomeprazole—Rigors—Metformin—metabolic syndrome X	0.0264	0.0267	CcSEcCtD
Esomeprazole—Accidental injury—Metformin—metabolic syndrome X	0.0244	0.0246	CcSEcCtD
Esomeprazole—Lightheadedness—Metformin—metabolic syndrome X	0.0193	0.0195	CcSEcCtD
Esomeprazole—Ear pain—Metformin—metabolic syndrome X	0.0184	0.0185	CcSEcCtD
Esomeprazole—Injury—Metformin—metabolic syndrome X	0.017	0.0172	CcSEcCtD
Esomeprazole—Renal impairment—Metformin—metabolic syndrome X	0.0165	0.0166	CcSEcCtD
Esomeprazole—Hypoglycaemia—Metformin—metabolic syndrome X	0.0161	0.0162	CcSEcCtD
Esomeprazole—Pain in extremity—Metformin—metabolic syndrome X	0.0157	0.0158	CcSEcCtD
Esomeprazole—Migraine—Metformin—metabolic syndrome X	0.0154	0.0156	CcSEcCtD
Esomeprazole—Abdominal pain upper—Metformin—metabolic syndrome X	0.0143	0.0144	CcSEcCtD
Esomeprazole—Breast disorder—Metformin—metabolic syndrome X	0.0142	0.0143	CcSEcCtD
Esomeprazole—Cramp muscle—Metformin—metabolic syndrome X	0.0141	0.0142	CcSEcCtD
Esomeprazole—Abdominal distension—Metformin—metabolic syndrome X	0.0136	0.0137	CcSEcCtD
Esomeprazole—Influenza—Metformin—metabolic syndrome X	0.0135	0.0137	CcSEcCtD
Esomeprazole—Pancreatitis—Metformin—metabolic syndrome X	0.0133	0.0134	CcSEcCtD
Esomeprazole—Angina pectoris—Metformin—metabolic syndrome X	0.0132	0.0133	CcSEcCtD
Esomeprazole—Sweating increased—Metformin—metabolic syndrome X	0.0132	0.0133	CcSEcCtD
Esomeprazole—Neutropenia—Metformin—metabolic syndrome X	0.0127	0.0128	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0126	0.0127	CcSEcCtD
Esomeprazole—Infestation NOS—Metformin—metabolic syndrome X	0.0121	0.0122	CcSEcCtD
Esomeprazole—Infestation—Metformin—metabolic syndrome X	0.0121	0.0122	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Metformin—metabolic syndrome X	0.0114	0.0115	CcSEcCtD
Esomeprazole—Bradycardia—Metformin—metabolic syndrome X	0.011	0.0111	CcSEcCtD
Esomeprazole—Rhinitis—Metformin—metabolic syndrome X	0.0109	0.011	CcSEcCtD
Esomeprazole—Hepatitis—Metformin—metabolic syndrome X	0.0108	0.0109	CcSEcCtD
Esomeprazole—Hypoaesthesia—Metformin—metabolic syndrome X	0.0108	0.0109	CcSEcCtD
Esomeprazole—Oedema peripheral—Metformin—metabolic syndrome X	0.0107	0.0108	CcSEcCtD
Esomeprazole—Connective tissue disorder—Metformin—metabolic syndrome X	0.0106	0.0107	CcSEcCtD
Esomeprazole—Eye disorder—Metformin—metabolic syndrome X	0.0101	0.0102	CcSEcCtD
Esomeprazole—Flushing—Metformin—metabolic syndrome X	0.0101	0.0101	CcSEcCtD
Esomeprazole—Immune system disorder—Metformin—metabolic syndrome X	0.00979	0.00987	CcSEcCtD
Esomeprazole—Mediastinal disorder—Metformin—metabolic syndrome X	0.00977	0.00985	CcSEcCtD
Esomeprazole—Chills—Metformin—metabolic syndrome X	0.00972	0.00981	CcSEcCtD
Esomeprazole—Malnutrition—Metformin—metabolic syndrome X	0.00943	0.00951	CcSEcCtD
Esomeprazole—Flatulence—Metformin—metabolic syndrome X	0.0093	0.00938	CcSEcCtD
Esomeprazole—Dysgeusia—Metformin—metabolic syndrome X	0.00924	0.00932	CcSEcCtD
Esomeprazole—Muscle spasms—Metformin—metabolic syndrome X	0.00907	0.00915	CcSEcCtD
Esomeprazole—Vision blurred—Metformin—metabolic syndrome X	0.00889	0.00897	CcSEcCtD
Esomeprazole—Tremor—Metformin—metabolic syndrome X	0.00884	0.00891	CcSEcCtD
Esomeprazole—Ill-defined disorder—Metformin—metabolic syndrome X	0.00875	0.00883	CcSEcCtD
Esomeprazole—Malaise—Metformin—metabolic syndrome X	0.00851	0.00858	CcSEcCtD
Esomeprazole—Palpitations—Metformin—metabolic syndrome X	0.00834	0.00841	CcSEcCtD
Esomeprazole—Hypertension—Metformin—metabolic syndrome X	0.00814	0.00821	CcSEcCtD
Esomeprazole—Chest pain—Metformin—metabolic syndrome X	0.00803	0.0081	CcSEcCtD
Esomeprazole—Myalgia—Metformin—metabolic syndrome X	0.00803	0.0081	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00798	0.00804	CcSEcCtD
Esomeprazole—Discomfort—Metformin—metabolic syndrome X	0.00794	0.008	CcSEcCtD
Esomeprazole—Infection—Metformin—metabolic syndrome X	0.00765	0.00771	CcSEcCtD
Esomeprazole—Shock—Metformin—metabolic syndrome X	0.00757	0.00764	CcSEcCtD
Esomeprazole—Nervous system disorder—Metformin—metabolic syndrome X	0.00755	0.00762	CcSEcCtD
Esomeprazole—Thrombocytopenia—Metformin—metabolic syndrome X	0.00754	0.0076	CcSEcCtD
Esomeprazole—Skin disorder—Metformin—metabolic syndrome X	0.00748	0.00754	CcSEcCtD
Esomeprazole—Hyperhidrosis—Metformin—metabolic syndrome X	0.00744	0.00751	CcSEcCtD
Esomeprazole—Anorexia—Metformin—metabolic syndrome X	0.00734	0.0074	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00701	0.00707	CcSEcCtD
Esomeprazole—Paraesthesia—Metformin—metabolic syndrome X	0.00691	0.00697	CcSEcCtD
Esomeprazole—Dyspnoea—Metformin—metabolic syndrome X	0.00686	0.00692	CcSEcCtD
Esomeprazole—Somnolence—Metformin—metabolic syndrome X	0.00684	0.0069	CcSEcCtD
Esomeprazole—Dyspepsia—Metformin—metabolic syndrome X	0.00678	0.00684	CcSEcCtD
Esomeprazole—Decreased appetite—Metformin—metabolic syndrome X	0.00669	0.00675	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00665	0.0067	CcSEcCtD
Esomeprazole—Fatigue—Metformin—metabolic syndrome X	0.00664	0.00669	CcSEcCtD
Esomeprazole—Constipation—Metformin—metabolic syndrome X	0.00658	0.00664	CcSEcCtD
Esomeprazole—Feeling abnormal—Metformin—metabolic syndrome X	0.00634	0.0064	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0063	0.00635	CcSEcCtD
Esomeprazole—Urticaria—Metformin—metabolic syndrome X	0.00612	0.00617	CcSEcCtD
Esomeprazole—Abdominal pain—Metformin—metabolic syndrome X	0.00609	0.00614	CcSEcCtD
Esomeprazole—Asthenia—Metformin—metabolic syndrome X	0.00552	0.00557	CcSEcCtD
Esomeprazole—Pruritus—Metformin—metabolic syndrome X	0.00545	0.00549	CcSEcCtD
Esomeprazole—Diarrhoea—Metformin—metabolic syndrome X	0.00527	0.00531	CcSEcCtD
Esomeprazole—Dizziness—Metformin—metabolic syndrome X	0.00509	0.00513	CcSEcCtD
Esomeprazole—Vomiting—Metformin—metabolic syndrome X	0.0049	0.00494	CcSEcCtD
Esomeprazole—Rash—Metformin—metabolic syndrome X	0.00485	0.0049	CcSEcCtD
Esomeprazole—Dermatitis—Metformin—metabolic syndrome X	0.00485	0.00489	CcSEcCtD
Esomeprazole—Headache—Metformin—metabolic syndrome X	0.00482	0.00486	CcSEcCtD
Esomeprazole—Nausea—Metformin—metabolic syndrome X	0.00457	0.00461	CcSEcCtD
Esomeprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—EPHX2—metabolic syndrome X	0.000951	0.112	CbGpPWpGaD
Esomeprazole—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.000496	0.0583	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.000493	0.058	CbGpPWpGaD
Esomeprazole—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.000438	0.0515	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.000297	0.0349	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000244	0.0286	CbGpPWpGaD
Esomeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000238	0.028	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.000237	0.0279	CbGpPWpGaD
Esomeprazole—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.00022	0.0258	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.00022	0.0258	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000217	0.0255	CbGpPWpGaD
Esomeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.000217	0.0255	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.000186	0.0219	CbGpPWpGaD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000173	0.0203	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000167	0.0196	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000149	0.0175	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.000143	0.0168	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000136	0.016	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000133	0.0156	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000128	0.015	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000125	0.0146	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000118	0.0139	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000114	0.0134	CbGpPWpGaD
Esomeprazole—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00011	0.013	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000104	0.0122	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000103	0.0121	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	9.19e-05	0.0108	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—FMO3—metabolic syndrome X	9.17e-05	0.0108	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—FMO3—metabolic syndrome X	9.04e-05	0.0106	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—APOE—metabolic syndrome X	8.89e-05	0.0105	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOB—metabolic syndrome X	8.47e-05	0.00996	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—GGT1—metabolic syndrome X	8.47e-05	0.00995	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—EPHX2—metabolic syndrome X	8.06e-05	0.00948	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOB—metabolic syndrome X	7.55e-05	0.00888	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	7.16e-05	0.00841	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	7.15e-05	0.0084	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	6.99e-05	0.00822	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	6.7e-05	0.00788	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	6.37e-05	0.00749	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	5.98e-05	0.00702	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	5.51e-05	0.00648	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	5.44e-05	0.00639	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.31e-05	0.00624	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	4.96e-05	0.00583	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	4.85e-05	0.0057	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ALB—metabolic syndrome X	4.73e-05	0.00557	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	4.1e-05	0.00482	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	3.94e-05	0.00463	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—GGT1—metabolic syndrome X	3.15e-05	0.0037	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	3.14e-05	0.00369	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	2.51e-05	0.00295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	2.38e-05	0.0028	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	2.07e-05	0.00243	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	2.02e-05	0.00238	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	1.96e-05	0.0023	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	1.94e-05	0.00228	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	1.9e-05	0.00223	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	1.8e-05	0.00212	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	1.61e-05	0.00189	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	1.6e-05	0.00188	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FMO3—metabolic syndrome X	1.57e-05	0.00184	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	1.55e-05	0.00182	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	1.48e-05	0.00175	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	1.44e-05	0.00169	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	1.4e-05	0.00165	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—EPHX2—metabolic syndrome X	1.4e-05	0.00164	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MLXIPL—metabolic syndrome X	1.4e-05	0.00164	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—G6PC2—metabolic syndrome X	1.31e-05	0.00154	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	1.25e-05	0.00147	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	1.21e-05	0.00142	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FABP4—metabolic syndrome X	1.12e-05	0.00131	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	1.06e-05	0.00125	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.03e-05	0.00121	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	9.99e-06	0.00117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	9.8e-06	0.00115	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—G6PD—metabolic syndrome X	9.44e-06	0.00111	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FMO3—metabolic syndrome X	9.43e-06	0.00111	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	9.32e-06	0.0011	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	9.22e-06	0.00108	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPA—metabolic syndrome X	9.01e-06	0.00106	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCKR—metabolic syndrome X	9.01e-06	0.00106	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	8.72e-06	0.00103	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	8.66e-06	0.00102	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA5—metabolic syndrome X	8.64e-06	0.00102	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	8.41e-06	0.000988	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	8.41e-06	0.000988	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	8.39e-06	0.000986	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	8.22e-06	0.000966	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	8.12e-06	0.000955	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	8.03e-06	0.000944	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	7.9e-06	0.000929	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	7.2e-06	0.000846	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.16e-06	0.000842	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LIPC—metabolic syndrome X	7.16e-06	0.000841	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCK—metabolic syndrome X	7.16e-06	0.000841	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOC3—metabolic syndrome X	7.11e-06	0.000836	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CETP—metabolic syndrome X	6.9e-06	0.000812	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FABP4—metabolic syndrome X	6.72e-06	0.00079	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	6.61e-06	0.000777	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.44e-06	0.000757	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	6.42e-06	0.000754	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	6.37e-06	0.000749	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	6.24e-06	0.000734	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GOT2—metabolic syndrome X	6.24e-06	0.000734	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—G6PD—metabolic syndrome X	5.68e-06	0.000667	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.63e-06	0.000662	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	5.56e-06	0.000654	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	5.56e-06	0.000654	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	5.54e-06	0.000651	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPA—metabolic syndrome X	5.42e-06	0.000637	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCKR—metabolic syndrome X	5.42e-06	0.000637	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GOT1—metabolic syndrome X	5.39e-06	0.000634	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GGT1—metabolic syndrome X	5.39e-06	0.000634	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	5.25e-06	0.000617	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA5—metabolic syndrome X	5.19e-06	0.00061	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	4.83e-06	0.000568	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOB—metabolic syndrome X	4.57e-06	0.000538	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	4.45e-06	0.000523	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—LPL—metabolic syndrome X	4.37e-06	0.000513	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	4.33e-06	0.000509	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LIPC—metabolic syndrome X	4.3e-06	0.000506	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCK—metabolic syndrome X	4.3e-06	0.000506	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOC3—metabolic syndrome X	4.28e-06	0.000503	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CETP—metabolic syndrome X	4.15e-06	0.000488	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD36—metabolic syndrome X	4.15e-06	0.000488	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	3.98e-06	0.000467	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	3.86e-06	0.000454	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARA—metabolic syndrome X	3.86e-06	0.000453	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	3.75e-06	0.000441	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GOT2—metabolic syndrome X	3.75e-06	0.000441	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGT—metabolic syndrome X	3.74e-06	0.000439	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOE—metabolic syndrome X	3.66e-06	0.00043	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA1—metabolic syndrome X	3.62e-06	0.000425	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	3.35e-06	0.000393	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	3.35e-06	0.000393	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GGT1—metabolic syndrome X	3.24e-06	0.000381	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GOT1—metabolic syndrome X	3.24e-06	0.000381	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—metabolic syndrome X	3.19e-06	0.000375	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—INS—metabolic syndrome X	3.13e-06	0.000368	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—metabolic syndrome X	2.87e-06	0.000337	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOB—metabolic syndrome X	2.75e-06	0.000323	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.74e-06	0.000322	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	2.68e-06	0.000314	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—LPL—metabolic syndrome X	2.63e-06	0.000309	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.51e-06	0.000295	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD36—metabolic syndrome X	2.49e-06	0.000293	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.32e-06	0.000273	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.25e-06	0.000264	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.2e-06	0.000259	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.18e-06	0.000256	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.92e-06	0.000225	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—INS—metabolic syndrome X	1.88e-06	0.000221	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.72e-06	0.000203	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.65e-06	0.000194	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.51e-06	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.26e-06	0.000148	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—metabolic syndrome X	7.58e-07	8.91e-05	CbGpPWpGaD
